BMJ: Avandia supporters had ties to Glaxo
After GlaxoSmithKline’s diabetes drug Avandia was linked to heart disease in May 2007, a fierce debate ensued, with much of it played out in scholarly journals. Just who wrote all those articles? That’s what the Mayo Clinic wanted to find out. Now, researchers have analyzed more than 200 articles that appeared after that infamous 2007 analysis published in the New England Journal of Medicine that
